The protective role of ROS in autoimmune disease

Trends Immunol. 2009 May;30(5):201-8. doi: 10.1016/j.it.2009.03.004. Epub 2009 Apr 6.

Abstract

For a long time, reactive oxygen species (ROS) produced by the phagocyte NADPH oxidase (NOX2) complex have been considered harmful mediators of inflammation owing to their highly reactive nature. However, there are an increasing number of findings suggesting that ROS produced by the NOX2 complex are anti-inflammatory and prevent autoimmune responses, thus challenging existing dogma. ROS might not only be produced as a mechanism to eradicate invading pathogens, but rather as a means by which to fine-tune the inflammatory response, depending on when, where and at what amounts they are produced. In this review, we aim to describe the current findings highlighting ROS as regulators of autoimmune inflammation, focusing on autoimmune arthritis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / metabolism*
  • Humans
  • Models, Biological
  • NADPH Oxidases / physiology
  • Oxidation-Reduction
  • Phagocytes / metabolism
  • Reactive Oxygen Species / immunology
  • Reactive Oxygen Species / metabolism*
  • T-Lymphocytes / physiology

Substances

  • Reactive Oxygen Species
  • NADPH Oxidases
  • neutrophil cytosolic factor 1